Daniel Espinouse

1.9k total citations
43 papers, 1.3k citations indexed

About

Daniel Espinouse is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel Espinouse has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Hematology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel Espinouse's work include Lymphoma Diagnosis and Treatment (14 papers), Neutropenia and Cancer Infections (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Daniel Espinouse is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Neutropenia and Cancer Infections (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Daniel Espinouse collaborates with scholars based in France. Daniel Espinouse's co-authors include Gilles Salles, Bertrand Coiffier, Charles Dumontet, Fadhela Bouafia, Catherine Thiéblemont, Isabelle Moullet, Olivier Héquet, Y Bastion, Daciana Antal and Anne Sonet and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Daniel Espinouse

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Espinouse France	19	590	584	410	356	209	43	1.3k
Fadhela Bouafia France	15	668 1.1×	818 1.4×	331 0.8×	333 0.9×	236 1.1×	24	1.5k
Rika Sakai Japan	24	526 0.9×	581 1.0×	465 1.1×	370 1.0×	61 0.3×	107	1.5k
Carlos Panizo Spain	19	463 0.8×	538 0.9×	287 0.7×	398 1.1×	70 0.3×	93	1.5k
İbrahim Barışta Türkiye	19	553 0.9×	510 0.9×	102 0.2×	254 0.7×	274 1.3×	72	1.3k
Delvyn C. Case United States	17	538 0.9×	511 0.9×	666 1.6×	404 1.1×	54 0.3×	42	1.4k
Patrizio Mazza Italy	22	680 1.2×	1.1k 1.8×	478 1.2×	516 1.4×	39 0.2×	98	1.8k
Nicole Straetmans Belgium	17	572 1.0×	546 0.9×	272 0.7×	333 0.9×	34 0.2×	44	1.1k
G. Janka‐Schaub Germany	18	345 0.6×	193 0.3×	491 1.2×	113 0.3×	123 0.6×	30	1.5k
Mieczysław Komarnicki Poland	19	384 0.7×	256 0.4×	580 1.4×	410 1.2×	129 0.6×	97	1.4k
Christoph Losem Germany	16	1.1k 1.8×	1.4k 2.3×	188 0.5×	898 2.5×	73 0.3×	46	1.9k

Countries citing papers authored by Daniel Espinouse

Since Specialization

Citations

This map shows the geographic impact of Daniel Espinouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Espinouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Espinouse more than expected).

Fields of papers citing papers by Daniel Espinouse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Espinouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Espinouse. The network helps show where Daniel Espinouse may publish in the future.

Co-authorship network of co-authors of Daniel Espinouse

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Espinouse. A scholar is included among the top collaborators of Daniel Espinouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Espinouse. Daniel Espinouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Perrier, Lionel, David Pérol, Philippe Quittet, et al.. (2013). Cost Effectiveness of Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Lymphoma and Myeloma. Applied Health Economics and Health Policy. 11(2). 129–138. 8 indexed citations

2.

Johnston, Anna, Gilles Salles, Daniel Espinouse, et al.. (2008). Epstein-Barr Virus—Induced Lymphoproliferative Disorder After Rituximab Combined with CHOP Therapy. Clinical Lymphoma & Myeloma. 8(6). 356–358. 6 indexed citations

3.

Thiéblemont, Catherine, Roch Houot, Gilles Salles, et al.. (2007). Non-Hodgkin’s lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome. Annals of Oncology. 19(4). 774–779. 107 indexed citations

4.

Thiéblemont, Catherine, Roch Houot, Catherine Traullé, et al.. (2005). Maintenance Alemtuzumab in Refractory B-Cell Chronic Lymphocytic Leukemia Patients: Updated Data.. Blood. 106(11). 5032–5032. 1 indexed citations

5.

Thomas, Xavier, Jean‐Michel Boiron, Françoise Huguet, et al.. (2004). Efficacy of granulocyte and granulocyte–macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study. The Hematology Journal. 5(5). 384–394. 13 indexed citations

6.

Lemieux, Bernard, Sophie Tartas, Catherine Traullé, et al.. (2004). Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma. Bone Marrow Transplantation. 33(9). 921–923. 69 indexed citations

7.

Héquet, Olivier, Gilles Salles, Nicolas Ketterer, et al.. (2003). Autoimmune thrombocytopenic purpura after autologous stem cell transplantation. Bone Marrow Transplantation. 32(1). 89–95. 32 indexed citations

8.

Thiéblemont, Catherine, Fadhela Bouafia, E. Hornez, et al.. (2003). Maintenance Therapy with a Monthly Injection of Alemtuzumab Prolongs Response Duration in Patients with Refractory B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (B-CLL/SLL). Leukemia & lymphoma. 45(4). 711–714. 23 indexed citations

9.

Thiéblemont, Catherine, Charles Dumontet, Fadhela Bouafia, et al.. (2002). Outcome in Relation to Treatment Modalities in 48 Patients with Localized Gastric MALT Lymphoma: A Retrospective Study of Patients Treated During 1976-2001. Leukemia & lymphoma. 44(2). 257–262. 29 indexed citations

10.

Dumontet, Charles, Catherine Thiéblemont, Daniel Espinouse, et al.. (2000). A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors. Leukemia. 14(12). 2159–2165. 4 indexed citations

11.

Ketterer, Nicolas, Daniel Espinouse, M. Chomarat, et al.. (1999). Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. The American Journal of Medicine. 106(2). 191–197. 36 indexed citations

12.

Ketterer, Nicolas, Anne Sonet, Charles Dumontet, et al.. (1999). Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution. Bone Marrow Transplantation. 23(12). 1309–1315. 12 indexed citations

13.

Ketterer, Nicolas, Gilles Salles, Michel Raba, et al.. (1998). High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation. Blood. 91(9). 3148–3155. 2 indexed citations

14.

Ketterer, Nicolas, Gilles Salles, Michel Raba, et al.. (1998). High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation. Blood. 91(9). 3148–3155. 167 indexed citations

15.

Dumontet, Charles, Nicolas Ketterer, Daniel Espinouse, et al.. (1998). Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma. Bone Marrow Transplantation. 21(10). 1037–1041. 15 indexed citations

16.

Girard, Delphine, et al.. (1994). [Major pancytopenia in Biermer disease. 5 cases].. PubMed. 145(3). 177–80. 1 indexed citations

17.

Chomarat, M., Daniel Espinouse, & Jean‐Pierre Flandrois. (1991). Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity. Journal of Antimicrobial Chemotherapy. 27(4). 475–480. 21 indexed citations

18.

Massignon, Denis, et al.. (1989). Apparition d'un anticoagulant circulant antifacteur V après intervention chirurgicale. Annales Françaises d Anesthésie et de Réanimation. 8(1). 70–72. 7 indexed citations

19.

Campos, Lydia, et al.. (1986). Variations in Morphological and Immunological Blast Cell Phenotype in a Case of Acute Leukaemia with t(4;11) Translocation. Acta Haematologica. 76(2-3). 169–172. 4 indexed citations

20.

Felman, Pascale, et al.. (1986). Intra‐cytoplasmic crystalline inclusions in acute myeloid leukemia: A rare event. Scandinavian Journal of Haematology. 36(5). 520–524. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact